Editorial Commentary: Early High-Dose Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Elevated Vancomycin Minimum Inhibitory Concentrations: Ready for Prime Time?

By Weston Adam   Boucher Helen W.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1570-1572

Oxford University Press

Access to resources Recommend Favorite

Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus : comparison with vancomycin, linezolid and daptomycin

By Mélard Aurélie   Garcia Laetitia G.   Das Debaditya   Rozenberg Raoul   Tulkens Paul M.   Van Bambeke Françoise   Lemaire Sandrine  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 648-658

Oxford University Press

Access to resources Recommend Favorite

Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?

By Goldstein Ellie J. C.   van Hal Sebastiaan J.   Fowler Vance G.  

Clinical Infectious Diseases, Vol. 56, Iss. 12, 2013-06 ,pp. : 1779-1788

Oxford University Press

Access to resources Recommend Favorite

Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus

By Leonard Steven N.   Rolek Kiri M.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 644-647

Oxford University Press

Access to resources Recommend Favorite

Treatment of Methicillin-Susceptible Staphylococcus aureus Osteoarticular and Prosthetic Joint Infections: Using the Oxacillin Minimum Inhibitory Concentration to Guide Appropriate Ceftriaxone Use

By Nguyen Hien M.   Jones Ronald N.  

Clinical Infectious Diseases, Vol. 57, Iss. 1, 2013-07 ,pp. : 161-162

Oxford University Press

Access to resources Recommend Favorite